Click here to unsubscribe
Click here to subscribe
   
     
 
 
Issue 5, December 2003
Welcome to the Northbank newsletter
 

2003 has been a busy and eventful year. Just over a year has passed since the launch of Northbank Communications as a new brand in the science communications sector, following the merger of Charles Consultants into STMP Marketing. The first half of the year was one of the most depressed periods in the Life Sciences sector and against this backdrop we were delighted to achieve growth. As the year draws to a close positive sentiment is returning, share prices are up, mergers are happening and, we are delighted to say, Northbank has had its busiest period ever. I'd like to thank our loyal clients and those that have joined the fold more recently. We look forward to achieving even greater success together in 2004.
Sue Charles, CEO

Contents
Identity provides unified front
First human genome chip
Oxford BioMedica and gene therapy
Medical Futures Awards
Northbank wins first Finnish client
Sigma Aldrich at CPhI
Promotion creates new Creative Director role
Northbank Account Manager
achieves MBA
Northbank strengthens team
Event round-up
New business wins
Client round-up
Meet us at

In brief

In October, Ipsat Therapies Ltd appointed Northbank Communications as its communications advisor, working on a range of projects including design and media outreach. Ipsat is based in Espoo, near Helsinki, and is Northbank’s first Finnish client. Leading the Ipsat account is Associate Director Katja Stout, a native Finn herself and fluent Finnish speaker. More...


As part of Northbank’s PR consultancy for Sigma Aldrich in Europe, Northbank was asked to help the company with media relations around this year’s European CPhI conference in FrankfurtMore...


Northbank Communications has announced the promotion of its Senior Designer, Chris Fisher, to the newly created role of Creative Director. This new role reflects the further strengthening of Northbank’s creative team. More...


Stefan Platz, Account Manager and Head of the Munich office for Northbank Communications Ltd has successfully graduated with an MBA in Entrepreneurship for Applied Biomedicine from the Danube University in Krems, Austria. His final year thesis focused on financial reporting for biotech companies. More...

After a busy year, Northbank Communications is celebrating the arrival of two new additions to its Congleton team, Tracy Williamson as Administrator and Clare McLeavy joins the studio as Traffic Manager. More...


Event round-up
View event round-up

Corporate identity provides unified front through UK biotech consolidation

Following the high profile merger between British Biotech, RiboTargets and Vernalis, a priority was placed on creating a strong corporate identity for the new company, Vernalis plc, that would strengthen the Company and project a unified image to the market.

Vernalis' new identity was launched at the start of October 2003, including the new website www.vernalis.com and is now being rolled out to further projects. More...

 
 

Affymetrix first to launch complete human
genome chip

This year saw a race by DNA array manufacturers to launch a Gene Chip containing the whole expressed human genome on a single chip. Affymetrix, a world leader in array technology, came first in October with the launch of its U133 Plus array.

 
As part of its ongoing PR support for Affymetrix, Northbank was commissioned to announce the launch of the U133 Plus array in Europe via the media and at a press conference during the BioTechnica conference in Hanover. More...

Encouraging responsible
reporting in gene therapy: raising
Oxford BioMedica’s profile

As part of its ongoing PR support for Oxford BioMedica, Northbank identified an opportunity to raise the company’s profile around a recent Government Genetics White Paper. Following the considerable interest this created with journalists, Northbank organised a successful media briefing on gene therapy jointly, with the Science Media Centre. More...

 
 
 
 

 

Medical Futures winners grab headlines

Medical Futures Innovation Awards, now in a third successful year, culminated on 30 October with a high profile awards ceremony held at RIBA, the Royal Institute of British Architects, in London. The overall winner of this year’s awards was a novel ophthalmoscope, providing a low cost, simple to use alternative to existing designs and set to revolutionise healthcare in the developing world.

Northbank provided media relations support for Medical Futures, and worked closely with the sponsors of the awards to disseminate news on the individual winners. As a result, Medical Futures obtained TV coverage on London Tonight and Sky News, and also gained news and feature stories in the national and regional press (Financial Times, Daily Telegraph, Cambridge Evening News, The Cornishman), and scientific and trade press (New Scientist, Nature, BMA News, General Practitioner, Hospital Doctor, Chemist & Druggist). Northbank also worked to secure The Times as a media partner for the awards, resulting in a two page feature in the Body & Soul supplement.

Andy Goldberg, founder of Medical Futures, commented, “This year’s competition was of the highest standard yet, and I am delighted with the high level of awareness Northbank has achieved for the awards.”

The project was managed by Caroline Stupnicka and Katja Stout, who worked proactively with the media to generate interest and secure coverage. View case study

   
New business wins
 

Since September Northbank has... been appointed by ProImmune to provide PR support for the launch of it new Pro5™ product... been hired by Ipsat Therapies to design conference posters and provide media outreach surrounding BioPartnering Europe and to edit its business plan... been called in by Merlin Biosciences to support copywriting for a presentation for Sir Chris Evans at the FT Global Life Science Conference... been appointed by Prolysis to provide support on its business plan... been hired to provide PR and communications support to IntegraGen.

Client round-up
 

Since September Northbank has... organised a gene therapy briefing with the Science Media Centre for Oxford BioMedica... obtained media coverage for the Medical Futures awards in The Times, Sky News, London Tonight, BBC Look East, Financial Times, Daily Telegraph, The Guardian, The New Scientist... designed posters for Vernalis and Arakis for stands at BioPartnering Europe... completed a website for Vernalis... developed a PowerPoint presentation for Arakis... completed work on Inpharmatica’s Private Placement Memorandum and investor presentation and been commissioned to design and write a new website for them... designed a new advertisement for Tecan... to give just a snapshot of our activities.

Meet us at

 
In the second half of the year members of the Northbank team are planning to attend the following events. Just click on the attendee if you would like to fix up a meeting with us. Please visit our website for updated information on events we will be attending throughout the year.
 
Event Date Location Attendees
Sachs Forum 27 January Munich Sue Charles / Stefan Platz
BIA Annual Dinner 29 January London Sue Charles / Fiona Brown
Medical Device and Technology 11 - 12 February Birmingham Nicola Reed Jones / Fiona Brown
IBC Drug Discovery Technology Europe 8 - 11 March London Katja Stout / Eileen Paul
BioSquare 10 - 12 March Basel Sue Charles / Stefan Platz
EC21 Biotech Conference 30 - 31 March London

Sue Charles / Katja Stout

BioCapital Europe 5 - 6 April Amsterdam Fiona Brown / Ellen Marriage
Human Genome Meeting 4 - 7 April Berlin Sue Charles / Rebecca Todd
Congleton
Tel: +44 (0)1260 296500
Fax: +44 (0)1260 296501
London
Tel: +44 (0)20 7886 8150
Fax: +44 (0)20 7886 8151
Munich
Tel: +49 (0) 89 2425 7311
Fax: +49 (0) 89 2425 7313

Email: info@northbankcommunications.com
www.northbankcommunications.com